Paper39339271
Analysis of Lipophilicity and Pharmacokinetic Parameters of Dipyridothiazine Dimers with Anticancer Potency.
Martula E and 3 others. Pharmaceutics, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Analysis of Lipophilicity and Pharmacokinetic Parameters of Dipyridothiazine Dimers with Anticancer Potency. Papers, record 39339271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39339271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analysis of Lipophilicity and Pharmacokinetic Parameters of Dipyridothiazine Dimers with Anticancer Potency.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| BNW-2-051/K/4/F | Medical University of Silesia | PubMed |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12546556 | Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. | J Chem Inf Comput Sci | 2003 | https://conductscience.org/library/papers/12546556 | PubMed |
| 2 | 38005384 | Synthesis and Structural Characterization of Novel Dimers of Dipyridothiazine as Promising Antiproliferative Agents. | Molecules | 2023 | https://conductscience.org/library/papers/38005384 | PubMed |
| 3 | 12826129 | Profiling drug-like properties in discovery research. | Curr Opin Chem Biol | 2003 | https://conductscience.org/library/papers/12826129 | PubMed |
| 4 | 12745926 | Neither lipophilicity nor membrane-perturbing potency of phenothiazine maleates correlate with the ability to inhibit P-glycoprotein transport activity. | Mol Membr Biol | 2003 | https://conductscience.org/library/papers/12745926 | PubMed |
| 5 | 34463935 | Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles. | Pharm Res | 2021 | https://conductscience.org/library/papers/34463935 | PubMed |
| 6 | 31736369 | Is there enough focus on lipophilicity in drug discovery? | Expert Opin Drug Discov | 2020 | https://conductscience.org/library/papers/31736369 | PubMed |
| 7 | 11259830 | Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. | Adv Drug Deliv Rev | 2001 | https://conductscience.org/library/papers/11259830 | PubMed |
| 8 | 30799643 | Lipophilicity in drug design: an overview of lipophilicity descriptors in 3D-QSAR studies. | Future Med Chem | 2019 | https://conductscience.org/library/papers/30799643 | PubMed |
| 9 | 11911703 | Predicting Caco-2 cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis. | J Chem Inf Comput Sci | 2002 | https://conductscience.org/library/papers/11911703 | PubMed |
| 10 | 9879505 | Multivariate analysis of experimental and computational descriptors of molecular lipophilicity. | J Comput Aided Mol Des | 1998 | https://conductscience.org/library/papers/9879505 | PubMed |
| 11 | 30070363 | Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches - a PEARRL review. | J Pharm Pharmacol | 2019 | https://conductscience.org/library/papers/30070363 | PubMed |
| 12 | 36677832 | Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments. | Molecules | 2023 | https://conductscience.org/library/papers/36677832 | PubMed |
| 13 | 37108135 | Study of Lipophilicity and ADME Properties of 1,9-Diazaphenothiazines with Anticancer Action. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108135 | PubMed |
| 14 | 29589935 | Lipophilic Efficiency as an Important Metric in Drug Design. | J Med Chem | 2018 | https://conductscience.org/library/papers/29589935 | PubMed |
| 15 | 24468238 | Rapid determination of octanol-water partition coefficient using vortex-assisted liquid-liquid microextraction. | J Chromatogr A | 2014 | https://conductscience.org/library/papers/24468238 | PubMed |
| 16 | 24464959 | Heterocycles 33: lipophilicity of a new class of thioethers estimated by reversed-phase thin-layer chromatography and different computational methods. | J Chromatogr Sci | 2014 | https://conductscience.org/library/papers/24464959 | PubMed |
| 17 | 30320896 | Lipidic prodrug approach for improved oral drug delivery and therapy. | Med Res Rev | 2019 | https://conductscience.org/library/papers/30320896 | PubMed |
| 18 | 30040971 | Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski's Rule of Five. | Int J Pharm | 2018 | https://conductscience.org/library/papers/30040971 | PubMed |
| 19 | 33679401 | Advances in Oral Drug Delivery. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/33679401 | PubMed |
| 20 | 30039409 | The Impact of Lipophilicity in Drug Discovery: Rapid Measurements by Means of Reversed-Phase HPLC. | Methods Mol Biol | 2018 | https://conductscience.org/library/papers/30039409 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42883808 | Comparative RP-HPTLC Lipophilicity Analysis of Bioactive 1,3,4-Thiadiazole-Resorcinol Conjugates. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883808 | PubMed |
| 41011127 | Use of TLC and Computational Methods to Determine Lipophilicity Parameters of Selected Neuroleptics: Comparison of Experimental and Theoretical Studies. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41011127 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39339271
GET https://conductscience.org/api/papers/v1/39339271/references?page=2